Financials

  • Market Capitalization 10.01 B
  • Employee 295
  • Founded 2016
  • CEO N/A
  • Website www.krystalbio.com
  • Headquarter Pennsylvania, United States
  • FIGI BBG00HDGRHH7
  • Industry Biotecnología
Ingresos totales
Beneficio neto
Beneficio básico por acción
Deuda total
Flujo de caja libre
Efectivo y equivalentes
Ratio precio/beneficio
34.58
Relación precio/flujo de caja
18.59

Related tickers

#NombrePrecio24h %7d %1M %1A %CapitalizaciónÚltimos 7 días
907
CYTK
Cytokinetics, Incorporated - Common Stock
81.93 USD-0.38%-3.61%+12.23%+41.02%10.19 B USD
909
ARWR
Arrowhead Pharmaceuticals, Inc. - Common Stock
71.91 USD-2.97%-16.26%-7.28%+83.91%10.13 B USD
925
NUVL
Nuvalent, Inc. - Class A Common Stock
123.96 USD+0.02%+0.18%+0.45%+30.55%9.79 B USD
930
CORT
Corcept Therapeutics Incorporated - Common Stock
90.47 USD+5.32%-2.47%+8.76%+23.31%9.71 B USD

Noticias